Infusion Therapy Devices

Global Infusion Therapy Devices Market to Reach US$69.5 Billion by 2030

The global market for Infusion Therapy Devices estimated at US$45.0 Billion in the year 2024, is expected to reach US$69.5 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Infusion Pumps, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$45.2 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.3 Billion While China is Forecast to Grow at 12.0% CAGR

The Infusion Therapy Devices market in the U.S. is estimated at US$12.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$14.9 Billion by the year 2030 trailing a CAGR of 12.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Infusion Therapy Devices Market – Key Trends & Drivers Summarized

Why Are Infusion Therapy Devices Becoming Increasingly Essential Across Clinical Settings?

Infusion therapy devices are becoming an indispensable part of modern healthcare as the demand for controlled, precise, and continuous administration of fluids, medications, nutrients, and blood products increases across hospital and outpatient environments. These devices are critical in delivering intravenous therapies for a wide range of conditions including cancer, infections, dehydration, chronic pain, and autoimmune diseases. Hospitals, ambulatory surgery centers, and home care providers rely on infusion pumps, IV sets, and catheters to ensure consistent dosing and patient safety. With an aging global population and the corresponding rise in chronic illnesses such as diabetes, cardiovascular disease, and cancer, the need for long-term and home-based infusion therapy is growing rapidly. This trend is pushing healthcare systems to shift from acute inpatient care toward more flexible, patient-centered delivery models. Infusion devices also play a key role in critical care and emergency medicine, where rapid, accurate delivery of medications can mean the difference between life and death. Pediatric and neonatal units require specially designed infusion systems that accommodate low-volume, highly sensitive dosages. Furthermore, the increasing use of biologic therapies and specialty pharmaceuticals, many of which require intravenous or subcutaneous delivery over extended periods, is expanding the therapeutic scope of infusion devices. With the emergence of value-based care models and hospital readmission penalties, ensuring safe and effective outpatient infusion is also becoming a cost-containment strategy. These factors together underscore the expanding importance of infusion therapy devices as the backbone of therapeutic administration across healthcare systems worldwide.

Can Technological Innovation Improve Safety and Efficiency in Infusion Therapy?

Technological innovation is revolutionizing the design and function of infusion therapy devices, making them safer, more accurate, and easier to use for both clinicians and patients. Traditional infusion pumps have evolved into smart devices capable of real-time monitoring, data logging, and integration with hospital information systems. Modern infusion pumps now include dose error reduction systems (DERS) that help prevent incorrect programming and reduce the risk of medication errors. These smart pumps feature built-in drug libraries and alert systems that notify nurses and pharmacists of deviations from prescribed dosage parameters, thereby improving patient safety. Wireless connectivity allows for remote monitoring and automatic documentation in electronic health records, reducing the administrative burden on healthcare workers and enabling better tracking of infusion-related metrics. Portable and wearable infusion devices have also advanced significantly, offering greater mobility for patients requiring continuous therapy in home or ambulatory settings. Innovations in microfluidics and sensor integration are leading to the development of infusion systems that automatically adjust flow rates based on patient-specific variables, such as body weight or fluid balance. Battery technology improvements have extended operating times and allowed for more compact form factors. In addition, advancements in materials science are producing more durable and biocompatible catheter lines, minimizing the risk of infections and adverse reactions. Artificial intelligence is beginning to influence infusion therapy as well, with predictive algorithms helping to identify potential complications like occlusions or air-in-line incidents before they occur. These continuous improvements are enhancing not only the technical performance of infusion therapy devices but also the overall clinical workflow, enabling more efficient and personalized care.

How Do Different Medical Specialties Influence the Customization and Use of Infusion Devices?

The infusion therapy devices market is characterized by high specialization, with different medical fields requiring unique features and performance standards tailored to their specific clinical applications. In oncology, for example, infusion devices must accommodate complex chemotherapy regimens that involve precise dosing schedules and delivery of cytotoxic agents that require specialized safety features to protect healthcare personnel. In infectious disease management, especially during outbreaks or pandemics, infusion pumps must support rapid deployment and high-volume usage for the delivery of antibiotics, antivirals, or hydration solutions. Pain management protocols in surgical and palliative care often rely on patient-controlled analgesia (PCA) pumps, which allow individuals to self-administer prescribed doses of pain medication within safe parameters. In critical care and neonatal units, infusion devices must support low-volume, highly precise dosing, sometimes down to the microliter level, and must be equipped with advanced alarms and fail-safes. Cardiology units use infusion therapy for vasopressors, inotropes, and anticoagulants, all of which require real-time monitoring and reliable rate control. In home healthcare, the focus is on portability, simplicity, and intuitive interfaces, as patients and caregivers must manage therapies without direct medical supervision. Even veterinary medicine uses infusion pumps designed for animals of different sizes, underscoring the market`s breadth. This clinical diversity has spurred manufacturers to develop a wide array of devices ranging from volumetric and syringe pumps to elastomeric and implantable systems. Regulatory compliance, user training, and compatibility with various infusion sets also vary depending on the medical discipline, influencing design priorities and purchasing decisions. As a result, the infusion therapy devices market has evolved into a highly segmented landscape where customization, safety, and usability remain central to product differentiation and clinical adoption.

What Is Driving the Rapid Growth of the Infusion Therapy Devices Market Worldwide?

The growth in the infusion therapy devices market is driven by several converging factors that span demographic trends, technological advancement, healthcare reform, and the rising burden of chronic disease. One of the most significant drivers is the global increase in aging populations, who are more susceptible to multiple chronic conditions requiring long-term and frequent infusion therapies. The expanding prevalence of diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular conditions further amplifies the need for continuous, reliable medication administration. The global shift toward outpatient care and home-based healthcare services is encouraging the development and adoption of portable, user-friendly infusion systems, allowing patients to receive treatment without lengthy hospital stays. At the same time, hospital and clinic administrators are seeking infusion solutions that streamline workflow, reduce human error, and support electronic documentation to meet regulatory standards and improve patient outcomes. Government investments in healthcare infrastructure, especially in emerging economies, are opening new markets for infusion devices and driving volume sales. Public health emergencies such as the COVID-19 pandemic have underscored the importance of scalable and rapidly deployable infusion solutions for treating large numbers of patients in intensive care settings. Moreover, reimbursement reforms in many countries are incentivizing value-based care, where accurate medication delivery and avoidance of adverse events directly impact provider compensation. Strategic collaborations between technology firms and medical device companies are also accelerating the pace of innovation, introducing smart features that align with the broader digital transformation of healthcare. Collectively, these drivers are creating a fertile environment for rapid growth, pushing the infusion therapy devices market toward greater technological sophistication, broader accessibility, and expanded clinical utility on a global scale.

SCOPE OF STUDY:

The report analyzes the Infusion Therapy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Infusion Pumps, Consumables, Accessories); End-Use (Hospitals End-Use, Homecare Settings End-Use, Clinics & Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Co.
• CareFusion Corporation
• CME Medical UK Ltd
• Eitan Medical
• Epic Medical
• Fresenius Kabi AG
• Hospira (Pfizer Inc.)
• ICU Medical, Inc.
• Insulet Corporation
• JMS Co., Ltd.
• Medtronic plc
• Moog Inc. (Medical Devices)
• Nipro Corporation
• Novo Nordisk A/S
• Promecon GmbH
• Smiths Medical
• Terumo Corporation
• Zyno Medical LLC

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more